Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dejun Sun

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
International Immunopharmacology|February 15, 2020
Sodium tanshinone IIA sulfonate protects against acute exacerbation of cigarette smoke-induced chronic obstructive pulmonary disease in miceDefu Li, Dejun Sun, Liang Yuan, et al.
American Journal of Physiology. Cell Physiology|May 20, 2016
Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-γ signaling axisQian Jiang, Wenju Lu, Kai Yang, et al.
ACS Central Science|March 4, 2024
Plasmonic Alloys Enhanced Metabolic Fingerprints for the Diagnosis of COPD and ExacerbationsHaiyang Su, Yuanlin Song, Shouzhi Yang, et al.
Microbiological Research|October 6, 2022
Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertensionJiyuan Chen, Dansha Zhou, Jinrui Miao, et al.
American Journal of Respiratory Cell and Molecular Biology|June 19, 2019
Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal TransitionJunyi Huang, Wenju Lu, Haiping Ouyang, et al.
Scientific Reports|January 12, 2018
Tanshinone IIA sulfonate protects against cigarette smoke-induced COPD and down-regulation of CFTR in miceDefu Li, Jian Wang, Dejun Sun, et al.
Zhonghua Yi Xue Za Zhi|April 29, 2015
[Present status of medical treatment for patients with chronic obstructive pulmonary disease based upon different severity classifications]Lina Sun, Yahong Chen, Chun Chang, et al.
Ebiomedicine|April 15, 2016
A Functional Variant rs6435156C > T in BMPR2 is Associated With Increased Risk of Chronic Obstructive Pulmonary Disease (COPD) in Southern Chinese PopulationJian Wang, Chenting Zhang, Zili Zhang, et al.
Frontiers in Pharmacology|May 17, 2018
Sodium Tanshinone IIA Sulfonate Decreases Cigarette Smoke-Induced Inflammation and Oxidative Stress via Blocking the Activation of MAPK/HIF-1α Signaling PathwayRuijuan Guan, Jian Wang, Ziying Li, et al.
ERJ Open Research|November 12, 2025
Identification of two distinct molecular endotypes in cough-variant asthma based on sputum transcriptomics and clinical pathophysiological featuresWenzhi Zhan, Wei Luo, Feng Wu, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
International Immunopharmacology|February 15, 2020
Sodium tanshinone IIA sulfonate protects against acute exacerbation of cigarette smoke-induced chronic obstructive pulmonary disease in miceDefu Li, Dejun Sun, Liang Yuan, et al.
American Journal of Physiology. Cell Physiology|May 20, 2016
Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-γ signaling axisQian Jiang, Wenju Lu, Kai Yang, et al.
ACS Central Science|March 4, 2024
Plasmonic Alloys Enhanced Metabolic Fingerprints for the Diagnosis of COPD and ExacerbationsHaiyang Su, Yuanlin Song, Shouzhi Yang, et al.
Microbiological Research|October 6, 2022
Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertensionJiyuan Chen, Dansha Zhou, Jinrui Miao, et al.
American Journal of Respiratory Cell and Molecular Biology|June 19, 2019
Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal TransitionJunyi Huang, Wenju Lu, Haiping Ouyang, et al.
Scientific Reports|January 12, 2018
Tanshinone IIA sulfonate protects against cigarette smoke-induced COPD and down-regulation of CFTR in miceDefu Li, Jian Wang, Dejun Sun, et al.
Zhonghua Yi Xue Za Zhi|April 29, 2015
[Present status of medical treatment for patients with chronic obstructive pulmonary disease based upon different severity classifications]Lina Sun, Yahong Chen, Chun Chang, et al.
Ebiomedicine|April 15, 2016
A Functional Variant rs6435156C > T in BMPR2 is Associated With Increased Risk of Chronic Obstructive Pulmonary Disease (COPD) in Southern Chinese PopulationJian Wang, Chenting Zhang, Zili Zhang, et al.
Frontiers in Pharmacology|May 17, 2018
Sodium Tanshinone IIA Sulfonate Decreases Cigarette Smoke-Induced Inflammation and Oxidative Stress via Blocking the Activation of MAPK/HIF-1α Signaling PathwayRuijuan Guan, Jian Wang, Ziying Li, et al.
ERJ Open Research|November 12, 2025
Identification of two distinct molecular endotypes in cough-variant asthma based on sputum transcriptomics and clinical pathophysiological featuresWenzhi Zhan, Wei Luo, Feng Wu, et al.
Pageof 15